You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

CLINICAL TRIALS PROFILE FOR GALLIUM NITRATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Gallium Nitrate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002543 ↗	Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors	Completed	National Cancer Institute (NCI)	Phase 1	1995-02-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor.
NCT00002543 ↗	Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors	Completed	Medical College of Wisconsin	Phase 1	1995-02-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor.
NCT00002578 ↗	Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma	Completed	National Cancer Institute (NCI)	Phase 2	1994-08-01	RATIONALE: Chemotherapy uses different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gallium nitrate in treating patients with AIDS-related non-Hodgkin's lymphoma.
NCT00002578 ↗	Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma	Completed	Roswell Park Cancer Institute	Phase 2	1994-08-01	RATIONALE: Chemotherapy uses different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gallium nitrate in treating patients with AIDS-related non-Hodgkin's lymphoma.
NCT00054808 ↗	Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma	Completed	Genta Incorporated	Phase 2	2002-06-01	Eligible patients will have low- or intermediate-grade Non-Hodgkin's Lymphoma (NHL) that has progressed after standard chemotherapy. Patients will receive gallium nitrate 300 mg/m2/day by continuous IV infusion for 7 consecutive days using a portable infusion pump. Hospitalization is not required. Stable or responding patients will receive additional gallium nitrate infusions every 3 weeks until the time of disease progression, for a maximum total of 8 infusions, or 2 cycles after complete remission has been documented.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Gallium Nitrate

Condition Name

Chart
Table

Condition Name for Gallium Nitrate
Intervention	Trials
Cystic Fibrosis	2
Lymphoma	2
Non-Hodgkin's Lymphoma	1
Nontuberculous Mycobacterium Infection	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Gallium Nitrate
Intervention	Trials
Lymphoma	4
Fibrosis	3
Cystic Fibrosis	3
Lymphoma, Non-Hodgkin	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Gallium Nitrate

Trials by Country

Map
Table

Trials by Country for Gallium Nitrate
Location	Trials
United States	41
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Gallium Nitrate
Location	Trials
Maryland	4
Washington	3
South Carolina	2
Pennsylvania	2
Ohio	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Gallium Nitrate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Gallium Nitrate
Clinical Trial Phase	Trials
Phase 2	4
Phase 1	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Gallium Nitrate
Clinical Trial Phase	Trials
Completed	5
Recruiting	1
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gallium Nitrate

Sponsor Name

Chart
Table

Sponsor Name for Gallium Nitrate
Sponsor	Trials
Cystic Fibrosis Foundation	3
University of Washington	2
National Cancer Institute (NCI)	2
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Gallium Nitrate
Sponsor	Trials
Other	11
NIH	2
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.